Cenexi: Gland Pharma, a Fosun Subsidiary, to Buy French CDMO for $124 Million

India's Gland Pharma, a majority owned CDMO subsidiary of Fosun Pharma, will expand its geographical footprint by paying $124 million to acquire France's Cenexi Group. Both companies focus on CDMO services for injectable products. Founded in 2004, Cenexi offers CDMO services with expertise in sterile liquid and lyophilized fill-finished drugs, including oncology and complex products. In 2017, Fosun paid $1.1 billion for a 74% stake in Gland. Now, Fosun owns 58% of Gland, which has a market cap of $3.8 billion. More details....Stock Symbols: (SHA: 600196; HK: 2196)Share this with colleagues: